摘要
目的通过对2004～2005年本院呼吸内科临床确诊为社区获得性肺炎的住院患者的抗菌药物使用情况调查分析,对照《社区获得性肺炎诊断与治疗指南》(草案),指导临床用药。方法采用回顾性分析方法,从医院病案室调出2004～2005年社区获得性肺炎住院患者病案资料,进行统计、分析。调查项目包括姓名、性别、年龄、住院天数、住院费用、用药费用、所用抗菌药物名称、药敏培养结果。结果2005年排名前3位的抗菌药物为左氧氟沙星、头孢哌酮/舒巴坦、依替米星;2004年为头孢哌酮钠/舒巴坦钠、左氧氟沙星、依替米星。联合用药、平均住院时间、平均药品费用差异无统计学意义,但药品费用比例有所减少。结论执行《社区获得性肺炎诊断与治疗指南》(草案)后,社区获得性肺炎患者抗菌药合理使用水平明显提高。2005年与2004年相比,用药趋于合理,但仍存在许多问题,有待改善。
Objective Depending on the analysis of patients who were diagnosed as Community - Acquired Pneumonia in our hospital during 2004-2005, we compared with 《Directory for Diagnose of Community -Acquired Pneumonia》（Draft） in order to provide the guidance for the rational antimicrobial use in clinic. Methods Using the Retrospective Analyze method,we analyzed the cases which included： Name, Sex, Age, time during in hospital, Fees, Medicine and Note. Results Compared from 2005 with 2004, the top 3 ranks of the DDDs in 2004 were cefoperazone sodium/sulbactam sodium;L -ofloxacin ; etimicin and in 2005 were L -ofloxacin; cefoperazone sodium/sulbactam ; etimicin. The rate of medicine fees were decreased,but the unites to use medicine,the average time in hospital and the average medicine fees were not deferent remarkable. Conclusions After 《Directory for Diagnose of Community - Acquired Pneumonia》 （Draft） was carried out, the condition of application was more rational in 2005 than in 2004, but there were still many problems should be improved.
出处
《医学研究杂志》
2007年第4期73-76,共4页
Journal of Medical Research
关键词
社区获得性肺炎
抗菌药物
药物利用
Community acquired pneumonia
Antibacterial
Medicine analysis
